Luping Lin, Sha Huang, Jianwei Yang. "Tislelizumab combined with bevacizumab and trifluridine/tipiracil as third-line or later therapy for metastatic colorectal cancer (mCRC) : A real-world study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e15554